AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2008
Mar 21, 2008
30786_dirs_2008-03-21_b4c09fcc-e3ab-4293-ace0-6c00aa097f25.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2003-02-05
Reporting Person: SCHWARTZ DAVID (Director, Chairman of the Board, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2003-02-05 | Incentive Stock Option (right to buy) | $39.60 | A | 2000 | Acquired | 2008-02-05 | Bio-Rad B Common Stock (2000) | Direct |
| 2003-02-05 | Non-Qualified Stock Option (right to buy) | $36.00 | A | 8000 | Acquired | 2013-02-05 | Bio-Rad B Common Stock (8000) | Direct |
Footnotes
F1: This stock option grant was inadvertently reported as a holding rather than a transaction on the Form 4 as originally filed. In addition, although the total number of shares for the two types of options included in this grant was reported correctly, the split between incentive and non-qualified stock options was incorrect on the report as originally filed.
F2: The option vests over five years at 20% per year beginning one year from the grant date.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13